Multiple Sclerosis: RO7121932 Treatment Study

We are investigating a new treatment for people with multiple sclerosis to see how safe it is and how well it works when given in different ways. This study will help us understand its effects on the immune system and overall health.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitair Ziekenhuis Gent
Neurology
Ledeberg, Belgium
Cliniques Universitaires Saint-Luc
Neurology
Sint-Stevens-Woluwe, Belgium
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
MS Center Dresden
Dresden, Germany

Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.